A new antibody has been developed to block immune suppression in aggressive breast cancer, offering a promising treatment.

Immunology 30, 189–202 (1976). CAS PubMed PubMed Central Google Scholar Köhler, G. & Milstein, C. Derivation of specific antibody-producing tissue culture and cell lines by cell fusion.

Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to ...

Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...

After a year that saw Ikena Oncology trim back its workforce and pipeline, the oncology biotech thinks it has found a ...

It is possible to substantially enhance these antibodies’ therapeutic potential via humanization, effectively reducing ...

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and ...

In a new study being published in Cell Reports, researchers from Prof. Idit Shachar’s laboratory at the Weizmann Institute of Science have discovered that a certain type of aggressive breast cancer ...

Boster Biological Technology is revolutionizing molecular biology with its advanced recombinant protein expression and custom ...

An antibody treatment that blocks the building of these bridges was shown to restore ... In an earlier study, researchers ...